Skip to main content

PCS Edventures! Announces Results for the Third Quarter of Fiscal Year 2026

MERIDIAN, Idaho, Feb. 13, 2026 (GLOBE NEWSWIRE) — PCS Edventures!, Inc. (“PCSV”), a leading provider of TK-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced results of operations for its third quarter of fiscal year 2026, which ended on December 31, 2025. Second Quarter FY 2026 Overview:Revenue increased 7.7% to $754,889 in the third quarter of FY 2026 compared to the prior year. Gross margin of 64.2% in the third quarter of FY 2026 compared to 50.3% in the third quarter of FY 2025. Net income before income tax provision was ($0.3 million) in the third quarter of FY 2026 versus ($0.4 million) in the previous year same quarter. During the quarter, the Company repurchased 379,270 shares of its common stock.Mike J. Bledsoe, President, commented, “The quarter ending December 31st is...

Continue reading

The Marketing Alliance Announces Financial Results for Fiscal Third Quarter Ended December 31, 2025

ST. LOUIS, Feb. 13, 2026 (GLOBE NEWSWIRE) — The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), announced its financial results today for its fiscal 2026 third quarter ended December 31, 2025. Q3 FY2026 Financial Key Items (all comparisons to the prior year quarter)Revenues from operations were $5,018,127 compared to $4,550,421, an increase of over 10% which was driven by an increase in revenue from the insurance distribution business Operating income from continuing operations of $299,637 compared to $(124,345) in the prior year quarter Net income was $268,692 or $0.04 per share in the quarter compared to $(164,867) or $(0.02) per share in the prior year quarter During the quarter the Company repurchased 117,962 shares, and subsequent to the end of quarter the Company has repurchased an additional 295,959 shares...

Continue reading

Astrotech Reports Second Quarter of Fiscal Year 2026 Financial Results

AUSTIN, Texas, Feb. 13, 2026 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2026, which ended December 31, 2025. Financial Highlights & Recent DevelopmentsResearch and development expense was $1,832 thousand, a decline of 25% from the second quarter of fiscal year 2025 as the Company transitions from development stage to saleable products for its EN-SCAN Handheld GC and 1st Detect Tracer 1000 product lines. Through December 31, 2025, the Company has deployed the TRACER 1000 trace detection system in approximately 35 locations in 16 countries across the United States, Europe and Asia.“We continue to see positive momentum in our sales pipeline across our global markets year-to-date in fiscal year 2026. Customers in...

Continue reading

Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update

Medicenna to present updated internal and external data sets related to bizaxofusp (MDNA55) at the 7th Annual Glioblastoma Development Summit to be held in Boston from 17-19 February 2026 Updated ABILITY-1 clinical data for MDNA11 demonstrates compelling activity in earlier-line expansion cohorts Among expansion cohorts treated with MDNA11 as a 2L or3L systemic treatment or as the next treatment following resistance to checkpoint therapy, MDNA11 demonstrated an objective response rate (“ORR”) of 36% (N=14) in the monotherapy setting and 43% (N=14) when combined with pembrolizumab The ABILITY-1 study has added a new expansion cohort where patients with non-small cell lung cancer (NSCLC) and secondary resistance to checkpoint therapy will be treated with MDNA11 in combination with pembrolizumab, potentially addressing the needs for one...

Continue reading

HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

– Cash position of US$195 million as of December 31, 2025, before adjustment for post quarter events –– Topline data readout from the Phase 2 study evaluating HLP004 in generalized anxiety disorder (“GAD”) expected in Q1 2026 – This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated September 17, 2025, as amended on December 19, 2025. BOSTON and TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — HELUS PharmaTM (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today reported unaudited financial results for its third quarter ended December 31, 2025, and recent business highlights. “The...

Continue reading

AtlasClear Holdings Reports 84% Revenue Growth, Profitability, and Positive Stockholders’ Equity for Fiscal Second Quarter 2026

-Revenue Increased 84% Year Over Year, Reflecting Accelerating Operating Momentum- –Stockholders’ Equity Turned Positive to $21.7 Million, Representing an Increase of ~$60 Million Compared to Fiscal Year-End 2024– -Liquidity Strengthened With $46.2 Million in Cash and Restricted Cash, Enhancing Financial Flexibility- -Wilson-Davis Net Capital Exceeded Regulatory Requirements by $14.4 Million, Underscoring Platform Strength- -Earnings Call Scheduled for Friday, February 13, 2026, at 8:30 AM ET- TAMPA, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) — AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a technology-enabled financial services platform modernizing trading, clearing, settlement, and banking infrastructure, today announced financial results for its fiscal second quarter ended December 31,...

Continue reading

Essent Group Ltd. Announces Fourth Quarter & Full Year 2025 Results and Increases Quarterly Dividend

HAMILTON, Bermuda, Feb. 13, 2026 (GLOBE NEWSWIRE) — Essent Group Ltd. (NYSE: ESNT) today reported net income for the quarter ended December 31, 2025 of $155.0 million or $1.60 per diluted share, compared to $167.9 million or $1.58 per diluted share for the quarter ended December 31, 2024. For the full year 2025, net income was $690.0 million or $6.90 per diluted share, compared to $729.4 million or $6.85 per diluted share for 2024. Essent also announced today that its Board of Directors has declared a quarterly cash dividend of $0.35 per common share. The dividend is payable on March 23, 2026 to shareholders of record on March 13, 2026. “We are pleased to report strong operating performance in the fourth quarter and full year 2025, which underscores the resilience of our business model and our ability to generate sustainable, long-term...

Continue reading

TC Energy reports fourth quarter and full-year 2025 results

Strongest safety performance in five years drives 15 flow records and solid financial results Progress in commercial discussions strengthens line of sight to incremental project announcements in 2026 Raises dividend for 26th consecutive year CALGARY, Alberta, Feb. 13, 2026 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) released its fourth quarter and full-year 2025 results today. François Poirier, TC Energy’s President and Chief Executive Officer commented, “Our safety-first culture is driving exceptional operational performance, leading to 15 flow records across our systems in 2025. Strong asset availability and reliability drove a 13 per cent year-over-year increase in fourth quarter comparable EBITDA1 and a 15 per cent increase in segmented earnings over the same period.” Poirier...

Continue reading

CLIQ Digital Reports Preliminary 2025 Results

4Q sales declined q/q by 43% to €12m and FY declined 46% y/y to €132m Total customer acquisition costs in 4Q were €1m and FY were €28m (-62% y/y) EBITDA for the year 2025 was -€6m (-163%) and -€4m for 4QDÜSSELDORF, 13 February 2026 – The CLIQ Group announces today its preliminary and unaudited 2025 headline financial results. On 5 March 2026, the audited 2025 Annual Report will be published on the company’s website at https://cliqdigital.com/investors/financialreporting. Performance (UNAUDITED)in millions of € 9M2025 4Q2025   FY 2025 FY 2024 ΔSales 120 12   132 243 -46%             Total Customer Acquisition Costs 27 1   28 75 -62%             EBITDA -2 -4   -6 10 -163%EBITDA margin -2% -34%   -5% 4%  About CLIQ The CLIQ Group sells bundled as well as single-content, subscription-based digital products to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.